Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
8 studies found for:    ABCA3
Show Display Options
Rank Status Study
1 Completed Genetic Regulation of Surfactant Deficiency
Condition: Respiratory Distress Syndrome, Newborn
Intervention: Drug: Nutrient
2 Recruiting Epidemiology of Surfactant Protein-B Deficiency
Conditions: Lung Diseases;   Respiratory Distress Syndrome, Newborn;   Pulmonary Surfactants
Intervention:
3 Completed Surfactant Disorders and Chronic Lung Disease
Condition: Chronic Lung Disease
Intervention: Other: whole blood sample
4 Recruiting Mendelian Reverse Cholesterol Transport Study
Conditions: Cholesterol, HDL;   Lipid Metabolism, Inborn Errors;   Tangier Disease;   LCAT Deficiency;   CETP Deficiency
Intervention: Drug: 3H-cholesterol bound to albumin
5 Unknown  Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine Cutaneous
Condition: Lamellar Ichthyosis
Intervention: Drug: apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side
6 Terminated Effects of Multiple Doses of CS-8080 in Healthy Volunteers
Condition: Healthy
Interventions: Drug: CS-8080;   Drug: placebo tablets
7 Recruiting Atherosclerosis in Rheumatoid Arthritis and Lupus: Restoring Cholesterol Balance
Condition: Rheumatoid Arthritis
Intervention:
8 Unknown  Pioglitazone Vs Placebo in Combination With Niacin Extended Release on Low HDL
Condition: Metabolic Syndrome
Intervention: Drug: Pioglitazone +/- placebo in combination with niacin ER

Indicates status has not been verified in more than two years